POST Online Media Lite Edition


Targovax appoints Oystein Soug as CEO

Staff Writer |
Oslo, Norway - November 3, 2016, Oslo, Norway - Targovax, an immuno-oncology company, announced that it has appointed Oystein Soug, currently the company's chief financial officer, to the role of chief executive officer.

Mr. Soug is the former CFO of Algeta, a Norwegian oncology biotech company which was sold to Bayer in 2014.

Prior to joining Algeta in 2008 Mr. Soug worked for six years at Orkla, lastly as CFO of Orkla’s Russian division.

Mr. Soug started his career as a banker with Credit Suisse and with the European Bank for Reconstruction and Development.


Aker Solutions appoints Ole Martin Grimsrud as CFO
Aker BP appoints Marit Blaasmo as senior vice president
Nordic Nanovector appoints Lisa Rojkjaer as chief medical officer
Norsk Hydro: head of Hydro's business area bauxite & alumina leaves
Telenor names Jorgen C. Arentz Rostrup as CFO

What to read next

Statoil names new Tanzania country manager
Collagen Matrix names Oystein Valberg as CFO
Vattenfall: Oystein Loseth new chief executive